戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 transplant, and 0.43 (95% CI, 0.39-0.48) for simultaneous pancreas-kidney transplant.
2 ime of listing, or who ultimately received a simultaneous pancreas-kidney transplant.
3 be considered as the preferred technique for simultaneous pancreas-kidney transplants.
4 ransplants were performed, 151 of which were simultaneous pancreas/kidney transplants.
5        During the study period a total of 65 simultaneous pancreas-kidney transplants, 13 pancreas af
6       One hundred eighty-three patients (50% simultaneous pancreas-kidney transplant, 42% pancreas af
7          The mean serum creatinine of the 30 simultaneous pancreas-kidney transplants at one year pos
8                                              Simultaneous pancreas-kidney transplant between identica
9                     Early in our experience, simultaneous pancreas-kidney transplant candidates were
10                           Most recipients of simultaneous pancreas-kidney transplants experience acut
11                                              Simultaneous pancreas-kidney transplant from living dono
12                                              Simultaneous pancreas-kidney transplants from live donor
13                                              Simultaneous pancreas-kidney transplant is the most comm
14 nts of cadaver, whole organ, bladder-drained simultaneous pancreas-kidney transplants (mean age, 37.6
15  April 18, 1996, 60 patients received either simultaneous pancreas-kidney transplant (n=55), pancreas
16  outcomes continue to improve for all types: simultaneous pancreas-kidney transplant, pancreas after
17                          We report the first simultaneous pancreas-kidney transplant performed betwee
18  on graft loss in a single-center kidney and simultaneous pancreas-kidney transplant population.
19 potentially favorable effect in the authors' simultaneous pancreas/kidney transplant program.
20 ric-drained (ED) versus bladder-drained (BD) simultaneous pancreas-kidney transplants (PTx) to determ
21    Here we present the case of a 49-year-old simultaneous pancreas-kidney transplant recipient who pr
22 the effect on clinical outcomes in renal and simultaneous pancreas kidney transplant recipients.
23 etrospective study comparing BD and ED in 71 simultaneous pancreas-kidney transplant recipients (37 B
24 no impact on kidney graft loss in kidney and simultaneous pancreas-kidney transplant recipients.
25 e needed to prevent and to treat late AMR in simultaneous pancreas-kidney transplant recipients.
26  to 2008 for liver, kidney, heart, lung, and simultaneous pancreas/kidney transplant recipients in th
27                                  Fifty-three simultaneous pancreas/kidney transplant recipients recei
28 mphocyte antibody therapy, in our kidney and simultaneous pancreas/kidney transplant recipients.
29 ases of pregnancy in 17 female recipients of simultaneous pancreas-kidney transplants resulted in 19
30 OT and the other kidney allocated for KAT or simultaneous pancreas-kidney transplant (SPK) (n = 7,378
31                                              Simultaneous pancreas-kidney transplant (SPK) is now a c
32 ted to be inferior to patient survival after simultaneous pancreas-kidney transplant (SPK).
33 jection rates and lower graft survivals than simultaneous pancreas-kidney transplants (SPK).
34                                              Simultaneous pancreas/kidney transplant (SPK) is an effe
35 In this first report of a clinical series of simultaneous pancreas-kidney transplants (SPKs) from liv
36      From December 1985 to October 1997, 500 simultaneous pancreas-kidney transplants (SPKs) were per
37 s to analyze and compare hospital charges in simultaneous pancreas-kidney transplant (SPKT) recipient
38  in combination with triple immunotherapy in simultaneous pancreas-kidney transplant (SPKT) recipient
39 V infection on patient and graft survival in simultaneous pancreas-kidney transplant (SPKT) recipient
40 Transplant Network database records for 9916 simultaneous pancreas-kidney transplants (SPKT) performe
41                     Pancreas graft status in simultaneous pancreas-kidney transplant (SPKTx) is curre
42  pancreas graft developed in 2 recipients of simultaneous pancreas-kidney transplant that were perfor
43 dneys, the IC overestimated DGF risk; (b) in simultaneous pancreas kidney transplants, the DGF risk w
44                                          For simultaneous pancreas-kidney transplants, the 1- and 3-y
45 ary 1990 and December 2000, 2,740 kidney and simultaneous pancreas-kidney transplants were performed
46  patients receiving a multiorgan (other than simultaneous pancreas-kidney) transplant were excluded,
47 eport our experience with four recipients of simultaneous pancreas-kidney transplants with acute reje